Impact of HBAIC in type 2 diabetes mellitus in Mexico:: Simulation analysis, a pharmacoeconomic perspective

被引：0
|
作者：
Castañeda, R. C. L. [1 ]
Sil, M. J. S. A. [1 ]
Acevedo, G. A. R. [1 ]
Manterola, S. O. M. C. [2 ]
Ramirez, J. R. [3 ]
Rios, L. R. N. [3 ]
Romero, S. R. [4 ]
Barquera, S. B. [5 ]
机构：
[1] Hosp Carlos Mc Gregor Sanchez Navarro, IMSS, Mexico City, DF, Mexico
[2] Sanofi Aventis Mexico, Mexico City, DF, Mexico
[3] Natl Inst Cardiol Ignacio Chavez, Mexico City, DF, Mexico
[4] Inst Mexicano Seguro Social, Zona Poniente, Toluca, Mexico
[5] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)64987-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [41] COMPARATIVE PHARMACOECONOMIC ANALYSIS OF TWO METFORMIN FOR-MULATIONS IN PATIENTS WITH DIABETES MELLITUS TYPE-2 AND ISCHEMIC HEART DISEASE
    Sabanov, A., V
    Matveev, N.
    Ashikhmin, Y.
    VALUE IN HEALTH, 2013, 16 (03) : A275 - A275
  • [42] SURVIVAL AS A FUNCTION OF HBAIC IN PEOPLE WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY
    Poole, C. D.
    Evans, L. M.
    Peters, J. R.
    Currie, C. J.
    VALUE IN HEALTH, 2010, 13 (03) : A56 - A56
  • [43] Pharmacoeconomic Aspects of Diabetes Mellitus: Outcomes and Analysis of Health Benefits Approach
    Baishnab, Suman
    Jaura, Ravinder Singh
    Sharma, Saksham
    Garg, Honey
    Singh, Thakur Gurjeet
    CURRENT DIABETES REVIEWS, 2024, 20 (08) : 12 - 22
  • [44] Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
    Su, Yu
    Zhang, Shuo
    Wu, Zezhen
    Liu, Weiting
    Chen, Jingxian
    Deng, Feiying
    Chen, Fengwu
    Zhu, Dan
    Hou, Kaijian
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [45] PHARMACOECONOMIC EVALUATION OF THE ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS IN THE RUSSIAN FEDERATION
    Ryazhenov, V. V.
    Emchenko, I., V
    VALUE IN HEALTH, 2013, 16 (07) : A440 - A440
  • [46] Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis
    Njoku, Kelechi
    Agnew, Heather J.
    Crosbie, Emma J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Challenges of Type 2 Diabetes Mellitus Management From the Perspective of Patients: Conventional Content Analysis
    Nikpour, Soghra
    Mehrdad, Neda
    Sanjari, Mahnaz
    Aalaa, Maryam
    Heshmat, Ramin
    Mafinejad, Mahboobeh Khabaz
    Larijani, Bagher
    Nomali, Mahin
    Ghezeljeh, Tahereh Najafi
    INTERACTIVE JOURNAL OF MEDICAL RESEARCH, 2022, 11 (02):
  • [48] BUDGET IMPACT ANALYSIS OF ADDING DAPAGLIFOZIN TO THE THERAPY OF DIABETES MELLITUS TYPE 2 IN BULGARIA
    Manova, M.
    Petkova, E.
    Yordanova, S.
    Petkova, V
    Petrova, G.
    VALUE IN HEALTH, 2014, 17 (07) : A337 - A337
  • [49] Prevention with picotamide and aspirin in patients with type 2 diabetes mellitus and peripheral arterial disease: A pharmacoeconomic evaluation
    Iannazzo, S.
    Pradelli, L.
    Eandi, M.
    VALUE IN HEALTH, 2006, 9 (06) : A225 - A225
  • [50] Primary prevention for type 2 diabetes: A pharmacoeconomic model
    Gentry, D
    Green, W
    Blackburne, E
    DIABETES, 2003, 52 : A520 - A520
12345